These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27789564)

  • 1. Lifetime attributable risk of radiation-induced secondary cancer from proton beam therapy compared with that of intensity-modulated X-ray therapy in randomly sampled pediatric cancer patients.
    Tamura M; Sakurai H; Mizumoto M; Kamizawa S; Murayama S; Yamashita H; Takao S; Suzuki R; Shirato H; Ito YM
    J Radiat Res; 2017 May; 58(3):363-371. PubMed ID: 27789564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.
    Suzuki S; Kato T; Murakami M
    J Radiat Res; 2021 Mar; 62(2):186-197. PubMed ID: 33341899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A treatment planning comparison between proton beam therapy and intensity-modulated x-ray therapy for recurrent nasopharyngeal carcinoma.
    Liu SW; Li JM; Chang JY; Yu JM; Chen Q; Jiang QA; Mu XK; Zhao MH; Tian Y; Wei QL
    J Xray Sci Technol; 2010; 18(4):443-50. PubMed ID: 21045280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.
    Shiraishi Y; Xu C; Yang J; Komaki R; Lin SH
    Radiother Oncol; 2017 Oct; 125(1):48-54. PubMed ID: 28917586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study.
    Mu X; Björk-Eriksson T; Nill S; Oelfke U; Johansson KA; Gagliardi G; Johansson L; Karlsson M; Zackrisson DB
    Acta Oncol; 2005; 44(6):554-62. PubMed ID: 16165914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field.
    Paganetti H; Athar BS; Moteabbed M; A Adams J; Schneider U; Yock TI
    Phys Med Biol; 2012 Oct; 57(19):6047-61. PubMed ID: 22968191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime attributable risk of radiation induced second primary cancer from scattering and scanning proton therapy - A model for out-of-field organs of paediatric patients with cranial cancer.
    Dell'Oro M; Short M; Wilson P; Peukert D; Hua CH; Merchant TE; Bezak E
    Radiother Oncol; 2022 Jul; 172():65-75. PubMed ID: 35504365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy.
    Yoon M; Shin DH; Kim J; Kim JW; Kim DW; Park SY; Lee SB; Kim JY; Park HJ; Park BK; Shin SH
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):637-46. PubMed ID: 20932690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of radiation-induced second cancers in the high to medium dose region: a comparison between passive and scanned proton therapy, IMRT and VMAT for pediatric patients with brain tumors.
    Moteabbed M; Yock TI; Paganetti H
    Phys Med Biol; 2014 Jun; 59(12):2883-99. PubMed ID: 24828559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient.
    Zhang R; Howell RM; Giebeler A; Taddei PJ; Mahajan A; Newhauser WD
    Phys Med Biol; 2013 Feb; 58(4):807-23. PubMed ID: 23322160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial.
    Chuong MD; Hartsell W; Larson G; Tsai H; Laramore GE; Rossi CJ; Wilkinson JB; Kaiser A; Vargas C
    Acta Oncol; 2018 Mar; 57(3):368-374. PubMed ID: 29034790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pencil-beam scanning proton therapy for anal cancer: a dosimetric comparison with intensity-modulated radiotherapy.
    Ojerholm E; Kirk ML; Thompson RF; Zhai H; Metz JM; Both S; Ben-Josef E; Plastaras JP
    Acta Oncol; 2015; 54(8):1209-17. PubMed ID: 25734796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of secondary cancer in nasopharyngeal carcinoma paediatric patients due to intensity modulated radiotherapy and mega-voltage cone beam computed tomography.
    Sherif RS; Attalla EM; Elshemey WM; Madian NG
    J Med Imaging Radiat Oncol; 2017 Jun; 61(3):402-409. PubMed ID: 28019086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second malignant neoplasm risk after craniospinal irradiation in X-ray-based techniques compared to proton therapy.
    Sakthivel V; Ganesh KM; McKenzie C; Boopathy R; Selvaraj J
    Australas Phys Eng Sci Med; 2019 Mar; 42(1):201-209. PubMed ID: 30725439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton beam therapy for the treatment of prostate cancer.
    Pugh TJ; Lee AK
    Cancer J; 2014; 20(6):415-20. PubMed ID: 25415688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients: Treatment Optimization Comparing Intensity Modulated X-rays, Volumetric Modulated Arc Therapy, and Intensity Modulated Proton Therapy.
    Vees H; Dipasquale G; Nouet P; Zilli T; Cozzi L; Miralbell R
    Technol Cancer Res Treat; 2015 Apr; 14(2):181-9. PubMed ID: 24694113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can We Spare the Pancreas and Other Abdominal Organs at Risk? A Comparison of Conformal Radiotherapy, Helical Tomotherapy and Proton Beam Therapy in Pediatric Irradiation.
    Jouglar E; Wagner A; Delpon G; Campion L; Meingan P; Bernier V; Demoor-Goldschmidt C; Mahé MA; Lacornerie T; Supiot S
    PLoS One; 2016; 11(10):e0164643. PubMed ID: 27764132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
    Vogel J; Lin L; Litzky LA; Berman AT; Simone CB
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):427-433. PubMed ID: 28871993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis using lifetime attributable risk of proton beam therapy for pediatric medulloblastoma in Japan.
    Yoshimura T; Tamori H; Morii Y; Hashimoto T; Shimizu S; Ogasawara K
    J Radiat Res; 2021 Sep; ():. PubMed ID: 34590123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential skin morbidity reduction with intensity-modulated proton therapy for breast cancer with nodal involvement.
    Fellin F; Iacco M; D'Avino V; Tommasino F; Farace P; Palma G; Conson M; Giacomelli I; Zucchetti C; Falcinelli L; Amichetti M; Aristei C; Cella L
    Acta Oncol; 2019 Jun; 58(6):934-942. PubMed ID: 30938217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.